• Biomolecules & Therapeutics
• /
• 제12권4호
• /
• pp.235-241
• /
• 2004

Gagam-danguiemja (GDGJ), a traditional Korean prescription, has been used as therapeutics for atopic allergic diseases such as atopic dermatitis. To evaluate the atopic allergic effect of modified GDGJ, we investigated a possible effect of GDGJ on mast cell-mediated allergic reaction, cytokinases secretion and mRNA expression in vivo and in vitro. Mast cells are a potent source of mediators that regulate the inflammatory response in allergic reaction. In mice orally administered by GDGJ (0.01, 0.1 and 1.0 g/kg) for 1 h, compound 48/80-induced ear oedema was significantly reduced. TNF-${\alpha}$, IL-8, and IL-6 secretion were inhibited by GDGJ in the human mast cell line (HNC-1). But TNF-${\alpha}$, IL-8, and IL-6 mRNA expression were not inhibited by GDGJ at the dose of 0.01 mg/ml. These findings may help in understanding the mechanism of action of this herbal medication, leading to the control of mast cells in atopic allergic reaction like AD.

• 한국식품저장유통학회지
• /
• 제20권4호
• /
• pp.583-591
• /
• 2013

본 연구에서는 밤나무 과실의 속껍질인 율피를 이용하여 알레르기성 피부질환 기능성 원료로 사용 가능성을 조사하였다. 율피 열수추출물과 율피 발효추출물의 총 폴리페놀 함량은 1 mg/mL에서 각각 $73.85{\pm}1.78$, $81.32{\pm}1.73{\mu}g/mL$였으며, 동일한 농도에서 총 플라보노이드 함량은 $18.72{\pm}0.20$, $14.70{\pm}0.21{\mu}g/mL$로 나타났다. 항산화 활성으로 율피 열수 추출물과 율피 발효추출물의 전자공여능은 1 mg/mL에서 각각 $73.74{\pm}1.18$, $67.17{\pm}1.87%$로 나타났으며, superoxide anion radical 소거능은 동일한 농도에서 각각 $91.58{\pm}2.51$, $100.15{\pm}4.30%$로 두 그룹 간 항산화 활성은 큰 차이를 보이지 않았다. HS68 세포를 대상으로 율피 열수추출물과 율피 발효추출물에 대한 세포 독성을 조사 한 결과, 율피 발효추출물에서 율피 추출물과 비교 시 세포 생존율이 1.33배 증가하였다. 또한 LPS로 유도된 RAW264.7 대식세포에서 0.05 mg/mL 율피 열수추출물과 율피 발효추출물 처리에 의한 NO생산량은 각각 $36.27{\pm}4.52$, $29.56{\pm}4.91{\mu}M$로 율피 발효 추출물 처리군에서 항염증 활성이 유의적으로 높았다. 아토피 유발 NC/Nga 마우스 모델에서 율피 열수추출물 및 율피 발효추출물을 도포하여 육안 상 관찰한 피부 병변은 율피 열수추출물 처리군에서 대조군과 비교해 피부 형태학적으로 일부 호전되는 경향을 보였으나, 율피 발효추출물 처리군은 멜라닌 함량과 피부 홍반의 감소 등 뚜렷한 개선효과를 보였으며 정상군과 유사한 피부 형태를 나타내었다. 또한 피부에 존재하는 염증성 사이토카인인 IL-$1{\beta}$와 TNF-${\alpha}$의 발현이 율피 열수추출물과 비교 시 율피 발효추출물에서는 각각 13.68, 3.63% 억제되었다. 이는 in vitro 실험과 유사하게 염증과 관련된 유전자의 발현을 저해함으로써 율피 발효추출물이 염증억제 효과는 물론 항아토피 효능을 나타내는 것으로 여겨진다. 따라서 율피 열수추출물 뿐만 아니라 율피 발효추출물 역시 아토피 피부질환을 개선하는데 유용한 물질로 활용될 수 있는 효과적인 조성물이라 사료된다.

• 공업화학
• /
• 제22권1호
• /
• pp.91-97
• /
• 2011

이 연구는 아토피 피부염이 유발된 hairless mice에 항 아토피 제품 처리를 통해 아토피 증상 개선 효과에 대해 알아 본 실험이다. 항 아토피 물질인 ceramide와 astaxanthin을 melt-homogenization 방법을 이용해 고형 지질 나노입자를 제조하고 입자 주위에 silk fibroin을 코팅시켰다. 동시에 고형 지질 나노입자를 함유하는 항 아토피 로션(lotion)과 크림(cream)을 만들어 타 사의 항 아토피 제품과 비교하였다. 아토피 피부염이 유발된 마우스의 외형적인 모습 관찰을 통해 ceramide와 silk fibroin을 함유한 항 아토피 제품인 FL과 FC는 아토피 피부염으로 손상된 피부 장벽을 재생 시키는 것을 확인하였고, 아토피 피부염이 유발된 피부 두께 역시 감소됨을 알 수 있었다. 면역학적 평가를 통해 silk fibroin과 astaxanthin 이 Th2 cytokine인 IgE와 IL-4의 발현을 억제하고 $IFN-{\gamma}$의 발현을 증가시켜 Th cell 사이의 균형을 이루게 하는 것이 밝혀졌다. 또한, 비장수치를 통해 T 림파구의 따른 IgE, IL-4 발현 억제능, 그리고 $IFN-{\gamma}$ 발현을 확인하였다.

• 대한한의학방제학회지
• /
• 제16권1호
• /
• pp.185-205
• /
• 2008

The purpose of this study is to determine whether the clinical activity of patients with atopic dermatitis(AD) correlate with their serum cytokine levels. 86 patients with AD were treated with KHS, YMH and GHT. On each visit to the clinic, their skin status was evaluated using the SCORAD index and serum IL-4, $IFN-{\gamma}$, IL-12, IL-13, IL-2 and IL-10 were measured by ELISA. After oral administration of herbal medicine, patients' skin status and subjective parameters such as pruritus and sleeplessness were significantly improved according to regression analysis. In particular, patients aged 0-9 showed stronger responses to treatment, which implies that the younger patients aged, the easier the treatment by herbal formula became. In analysis of the type of chosen herbal medicines, YMH treated group showed a stronger response in reduction of affected lesion, intensity of a lesion and subjective symptoms, while KHS treated group showed the least reduction. The levels of serum IL-4, $IFN-{\gamma}$ and IL-2 correlated with disease activity. Moreover, in patients under 0-9, the IL-4 level had a corrleation with disease activity; patients under 10-19 showed a correlation between the levels of IL-4 and IL-2 and disease activity; patients under 20-29 showed a correlation between the levels of IL-2, IL-12 and $IFN-{\gamma}$ and disease activity. In comparison with chosen herbal medicines, the groups treated with YMH or GHT treated group showed a correlation between the levels of IL-4, IL-12 and IL-2 and disease activity while KHS treated group did not. Our data suggest that serum levels of IL-4 and IL-13 are good indicators of clinical improvement in treating AD.

• 대한한방소아과학회지
• /
• 제30권4호
• /
• pp.29-59
• /
• 2016

Objectives PRAL (Prunus armeniaca Linne Var) has been known to suppress allergic reaction. However, the cellular target and its mechanism of action were unclear. This study was designed to investigate the effect of PRAL on RBL-2H3 mast cell, which is PMA-Ionomycin-induced activated in vitro and the effect of PRAL on the MNC/Nga mice that are DNCB-induced activated in vivo. Methods In this study, IL-4, IL-13 production were examined by ELISA analysis; IL-4, IL-13, IL-31, IL-31Ra, $TNF-{\alpha}$ and GM-CSF mRNA expression were examined by Real-time PCR; manifestations of AP-1 and MAPKs transcription factors were examined by western blotting in vitro. Then skin rashes have been evaluated and verified the distribution of mast cells by H&E and toluidine blue. Also, WBC, eosinophil and neutrophil, IgE level in serum, $IFN-{\gamma}$, IL-4, IL-5 in the splenocyte culture supernatant, the absolute cell numbers of $CD4^+$, $CD8^+$, $Gr-1^+CD11b^+$, $B220^+CD23^+$, $CD3^+CD69^+$ in the Axillary Lymph Node (ALN), PBMCs and dorsal skin and IL-5, IL-13, IL-31, IL-31Ra in the dorsal skin by Real-time PCR were all evaluated from the NC/BNga mice. Results As a result of this study, the mRNA expression of IL-4, IL-13, IL-31, IL-31Ra and $TNF-{\alpha}$ and IL-4, IL-13 production, shown in ELISA analysis, were suppressed by PRAL. Results from the western blot analysis showed decrease on the expression of mast-cell-specific transcription factors, including AP-1 and p-JNK, p-ERK. Histological examination showed that infiltration levels of immune cells in the skin of the AD-induced NC/Nga mice were improved by PRAL orally adminstration. Orally- administered PRAL group also showred decreased level of IgE in the serum. This group has shown decreased the level of IL-4, IL-5, but shown elevated $IFN-{\gamma}$ level in the splenocyte culture supernatant. The same group also has shown decreased cell numbers of $CD4^+$, $CD8^+$, $CD3^+CD69^+$ in the ALN, and $CD4^+$, $Gr-1^+CD11b^+$ in the dorsal skin. PRAL oral adminstration increased cell numbers of $CD4^+$, but decreased cell numbers of $CD8^+$, $Gr-1^+CD11b^+$, $B220^+CD23^+$ in the PBMCs. Conclusions Obtained results suggest that PRAL can regulate molecular mediators and immune cells that are functionally associated with atopic dermatitis (AD) induced in the NC/Nga mice. This may play an important role in recovering AD symptoms and suppressing pruritus.

• Journal of the Korean Academy of Child and Adolescent Psychiatry
• /
• 제10권1호
• /
• pp.34-42
• /
• 1999

본 연구는 정서 행동적 문제를 자주 동반하는 것으로 알려진 아토피피부염 소아 청소년에 대해, 정신과적 문제의 정도와 병변 심각도에 영향을 미칠 수 있는 심리 사회적요인을 알아보고자 하였다. 서울대학교병원 아토피 크리닉을 방문한 아토피피부염 환자 70명(평균 나이 9.9세, 범위：$4{\sim}15$세)과 그 어머니를 대상으로 병력조사설문지, CBCL, MBRI, CDI, STAI을 주어 완성하도록 한 후, 정신과적 면담을 시행하였다, 환자의 피부 병변에 대해 SCORAD index를 이용하여 침범부위, 병변의 경중도, 주관적 증상으로 나누어 평가하였다. 16명(22.9%)이 임상적으로 유의한 정서 행동적 문제가 있을 것으로 예측되었으며 이들은 우울, 특성 불안, 어머니의 통제적 태도, 부정적평가 척도에서 다른 아토피 군보다 점수가 높았다. 병변의 경중도는 특성불안이나 우울정도와, 주관적 증상은 우울, 특성불안, 가족영향, 사회능력, 내재화 및 외현화 문제, 성문제, 아이에 대한 부정적 평가와 관련이 있었다. 아토피피부염을 가진 소아 청소년은 정신과적 문제의 고위험군이며 이러한 정신과적 문제는 양육태도와 함께 피부증상의 주관적 지각에 영향을 미칠 가능성이 높다고 할 수 있다. 향후 이에 대한 정신과적 개입이 필요할 것으로 생각된다.

• 혜화의학회지
• /
• 제20권2호
• /
• pp.17-27
• /
• 2012

In order to investigate the possibility of Kamisamultang(KMSMT) as therapeutic for the treatment of atopic dermatitis(AD), cytotoxicity, anti-oxidant activity, modulatory and suppression activities of KMSMT were tested. 90% or higher cell viability was observed in all tested groups from 25 to 200 ${\mu}g/m{\ell}$ using Raw 264.7 cells. KMSMT showed dose-dependent DPPH scavenging activity, with more than 80% scavenging activities at 400 and 800 ${\mu}g/m{\ell}$ concentrations. KMSMT showed dose-dependent suppression activity of reactive oxygen species(ROS) production, especially at 200 ${\mu}g/m{\ell}$ of 42.6%. KMSMT decreased nitric oxide(NO) production activity dose dependently, expecially at 200 ${\mu}g/m{\ell}$ of 30.9%. IL-$1{\beta}$, IL-6, MCP-1, TNF-${\alpha}$ production rate were decreased by 45.7%, 15.5%, 8.9%, 16.5% respectively when Raw 264.7 cells were treated with LPS and with KMSMT of 200 ${\mu}g/m{\ell}$. However, only IL-$1{\beta}$ and MCP-1 showed significant changes. The results above strongly suggest the modulatory and suppressive effect of KMSMT. The results above indicate that KMSMT significantly reduces the effect of oxidative and inflammatory cytokines. The use of KMSMT in atopic dermatitis can be widely suggested.

• 동의생리병리학회지
• /
• 제32권6호
• /
• pp.396-402
• /
• 2018

Hataedock (HTD) treatment is a traditional preventive therapy for the fetal toxicosis- the acute allergic disease after childbirth, mainly manifested by a variety of skin allergies such as scab, phlegm. The aim of this study was to investigate the efficacy of HTD treatments for the alleviation of inflammation in Dermatophagoides farinae-induced obese NC/Nga mice. 20 mg/kg of Coptidis Rhizoma, Glycyrrhizae Radix (CRGR) extracts as a remedy of HTD treatments were orally administered to NC/Nga mice. We induced obesity in the mice by high-fat diet. To induce skin allergies, the extracts of Dermatophagoides farinae were topically applied on the NC/Nga mice at 4th-6th and 8th-10th weeks. Structural and molecular changes in the skin tissues were measured by immunohistochemical staining. HTD treatment decreased the atopic dermatitis (AD)-like symptoms including hemorrhage, erythema, erosion, edema, and dryness. HTD treatment suppressed the mast cell activation confirmed by reduction of $Fc{\varepsilon}RI$, substance P, and serotonin. The expression of several inflammatory mediators including nuclear factor-kappa B ($NF-{\kappa}B$) p65, inducible nitric oxide synthase (iNOS), vascular endothelial growth factors (VEGFs) was also decreased by HTD treatment. HTD treatment suppressed the allergic, inflammatory responses in the skin tissues of the NC/Nga mice by reducing mast cells and down-regulating several inflammatory mediators.

• 한국미생물·생명공학회지
• /
• 제42권1호
• /
• pp.82-88
• /
• 2014

본 연구는 DNCB 도포를 통해 아토피 피부염을 유발시킨 BALB/c mice에 SMEE를 2주 동안 지속적으로 처리하여 SMEE의 아토피 피부염 완화 효과에 대해 연구하였다. 따라서 IFN-${\gamma}$ 및 IL-4 cytokine의 분비량, 비장세포 증식능, 혈청 중 총 IgE 함량, 육안 평가 및 skin clinical severity score를 실시하였다. 그 결과 SMEE를 지속적으로 도포함으로써 IL-4 cytokine과 총 IgE 함량이 현저히 감소하는 것을 확인할 수 있었으며 IFN-${\gamma}$ cytokine은 유의적으로 증가하는 것을 확인하였다. 세포증식능 측정결과, SMEE 처리구의 경우 negative control군과 유사한 수준까지 억제됨을 나타냈으며, 비장세포의 비이상적인 증식에 SMEE 도포처리가 큰 영향을 미치지 않는 것으로 나타났다. 육안평가 및 skin clinical severity score 결과, SMEE를 2주간 지속적으로 도포 처리하였을 때, 그 증상이 눈에 띄게 완화되는 것을 확인할 수 있었으며 score 또한 positive control과 비교 시 유의적으로 감소하였다. 결과적으로 SMEE는 Th1 cytokine 생성은 증가시키고 Th2 cytokine 생성은 억제하여 IgE의 과다발현을 억제함으로써 아토피 피부염의 개선에 뛰어난 효능을 가지고 있는 것으로 사료된다.

• 한방안이비인후피부과학회지
• /
• 제18권1호
• /
• pp.116-134
• /
• 2005

Although the parallel prescription of Sopoongsangagambang (SG) administration along with external treatment such as spraying or ointment application on the skin is clinically used for the treatment of atopic dermatitis (AD), molecular mechanism underlying its effectiveness is unknown. Thus in the present study, diverse immune responses in terms of chemical mediators related to AD were investigated using an atopic mouse model NC/Nga after SG administration and external treatment (ET), and major findings are summarized as follows. 1. The clinical severities in 16 and 20 week old NC/Nga mice with SG and ET treatment were decreased to 72.2% and 62.3% respectively compared to the control NC/Nga mice with no drug treatment. 2. IgE, IL-4, IL-5, IL-6, IL-13, IgM, IgG1 and IgG2a levels in the serum of SG and ET treated NC/Nga mouse group were significantly decreased compared to the untreated control mice. In contrast, $IFN-{\gamma}$ showed a significant increase in the experimental group compared to the untreated control group. 3. The spleen weight of SG and ET treated NC/Nga mice was significantly decreased compared to the untreated control group. 4. The B/T ratio in the lymph node of SG and ET treated NC/Nga mice was increased compared to the untreated control group. $CD4^+\;and\;CD8^+$ cell numbers in the lymph node of SG and ET treated NC/Nga mice were significantly increased compared to the untreated control group, but $CD69^+\;and\;CD11a^+$ cells were significantly decreased. 5. mRNA expression levels of IL-4, IL-5, and CCR3 in the skin tissues of SG and ET treated NC/Nga mice were significantly decreased, and expression levels of IL-6, IL-13, $CD69^+/CD3{\varepsilon}^+\;and\;CD19^+/CD44^+$ in the skin tissues of SG and ET treated NC/Mga mice were significantly decreased compared to the untreated control group. $IFN-{\gamma}$ mRNA expression levels were increased compared to the untreated control group. 6. Histological observation of the ear and neck skin tissues showed that the extents of inflammation and infiltrated immune cells in the epidermis and dermis of SG and ET treated NC/Nga mice were highly reduced compared to the untreated control group. 7. Lymphokine assay showed a significant decrease in IL-4 levels in SG and ET treated NC/Nga mice compared to the untreated control group, but the levels of $IFN-{\gamma}$ secretion were significantly increased drug treated NC/Nga mice.